Filing Details
- Accession Number:
- 0000874015-14-000029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-31 19:34:13
- Reporting Period:
- 2014-01-29
- Filing Date:
- 2014-01-31
- Accepted Time:
- 2014-01-31 19:34:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1073385 | Lynne B Parshall | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-01-29 | 3,972 | $11.27 | 7,994 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-29 | 3,972 | $48.81 | 4,022 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-01-29 | 31,028 | $10.29 | 35,050 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-29 | 31,028 | $48.81 | 4,022 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-01-29 | 5,000 | $7.25 | 5,000 | No | 4 | M | Indirect | By daughter |
| Common Stock | Disposition | 2014-01-29 | 5,000 | $48.81 | 0 | No | 4 | S | Indirect | By daughter |
| Common Stock | Acquisiton | 2014-01-29 | 5,000 | $7.25 | 5,000 | No | 4 | M | Indirect | By daughter |
| Common Stock | Disposition | 2014-01-29 | 5,000 | $48.81 | 0 | No | 4 | S | Indirect | By daughter |
| Common Stock | Acquisiton | 2014-01-29 | 5,000 | $7.25 | 5,000 | No | 4 | M | Indirect | By son-in-law |
| Common Stock | Disposition | 2014-01-29 | 5,000 | $48.81 | 0 | No | 4 | S | Indirect | By son-in-law |
| Common Stock | Acquisiton | 2014-01-30 | 23,635 | $10.29 | 27,657 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-30 | 23,635 | $50.36 | 4,022 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-01-30 | 15,875 | $7.25 | 19,897 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-30 | 15,875 | $50.36 | 4,022 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Indirect | By daughter |
| No | 4 | S | Indirect | By daughter |
| No | 4 | M | Indirect | By daughter |
| No | 4 | S | Indirect | By daughter |
| No | 4 | M | Indirect | By son-in-law |
| No | 4 | S | Indirect | By son-in-law |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-01-29 | 3,972 | $0.00 | 3,972 | $11.27 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-01-29 | 31,028 | $0.00 | 31,028 | $10.29 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-01-29 | 5,000 | $0.00 | 5,000 | $7.25 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-01-29 | 5,000 | $0.00 | 5,000 | $7.25 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-01-29 | 5,000 | $0.00 | 5,000 | $7.25 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-01-30 | 23,635 | $0.00 | 23,635 | $10.29 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-01-30 | 15,875 | $0.00 | 15,875 | $7.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-01-04 | 2017-01-03 | No | 4 | M | Direct |
| 41,856 | 2015-01-03 | 2018-01-02 | No | 4 | M | Direct |
| 0 | 2013-01-03 | 2019-01-02 | No | 4 | M | Indirect |
| 0 | 2013-01-03 | 2019-01-02 | No | 4 | M | Indirect |
| 0 | 2013-01-03 | 2019-01-02 | No | 4 | M | Indirect |
| 18,221 | 2015-01-03 | 2018-01-02 | No | 4 | M | Direct |
| 30,874 | 2016-01-02 | 2019-01-02 | No | 4 | M | Direct |
Footnotes
- Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 12/30/13.
- Grant of 1/3/11 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/3/12. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 18,221 shares per year. The option shall be fully vested and exercisable on 1/3/15. The option was exercisable as to 54,663 shares on 1/29/14.
- Grant of 1/3/12 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/3/13. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 15,437 shares per year. The option shall be fully vested and exercisable on 1/3/16. The option was exercisable as to 15,875 shares on 1/30/14.
Billionaire Hedge Funds
